Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 25   

Articles published

DPH 770.00 +3.00 (0.39%)
price chart
Dechra Pharmaceuticals plc Receives "Buy" Rating from Panmure Gordon (DPH)
Dechra Pharmaceuticals plc logo Panmure Gordon reaffirmed their buy rating on shares of Dechra Pharmaceuticals plc (LON:DPH) in a report issued on Thursday.
Related articles »  
N+1 Singer Downgrades Dechra Pharmaceuticals plc to Hold (DPH)
Dechra Pharmaceuticals plc logo N+1 Singer lowered shares of Dechra Pharmaceuticals plc (LON:DPH) to a hold rating in a research report released on Thursday morning.
Weekly Research Analysts' Ratings Changes for Dechra Pharmaceuticals plc ...  Intercooler
Related articles »  
Dechra Pharmaceuticals plc's Buy Rating Reiterated at N+1 Singer (DPH)
Dechra Pharmaceuticals plc logo N+1 Singer reiterated their buy rating on shares of Dechra Pharmaceuticals plc (LON:DPH) in a research report sent to investors on Monday morning.
Dechra Pharmaceuticals plc Price Target Raised to GBX 860 at Investec (DPH)  Intercooler
Investec Reaffirms "Buy" Rating for Dechra Pharmaceuticals plc (DPH)  Ticker Report
Related articles »  
Panmure Gordon Reaffirms Buy Rating for Dechra Pharmaceuticals plc (DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH)'s stock had its �buy� rating reaffirmed by investment analysts at Panmure Gordon in a note issued to investors on Thursday.
Related articles »  
Dechra Pharmaceuticals plc Lowered to Hold at N+1 Singer (DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) was downgraded by stock analysts at N+1 Singer to a �hold� rating in a report issued on Thursday.
Related articles »  
Dechra Pharmaceuticals Posts Higher FY14 Pretax Profit
Dechra Pharmaceuticals PLC (OTC: DPHAF) reported a 72% rise in its fiscal 2014 pretax profit and lifted its dividend payment.
Dechra Pharma pretax profit up 72% in fiscal 2014  MarketWatch
Dechra Pharmaceuticals Full-Year Profit Rises; Ups Final Dividend - Quick Facts  RTT News
Related articles »  
DIRECTOR DEALINGS: Dechra CFO Exercises Options, Sells Shares
LONDON (Alliance News) - Dechra Pharmaceuticals PLC Thursday said Chief Financial Officer Anne-Francoise Nesmes exercised options under the company share plan over 41,739 shares and sold 19,677 of them for tax purposes at a price of GBP7.6017 ...
The Week Ahead: All bets off with FTSE if Scots opt for independence
UK corporate earnings announcements: Green Reit Plc (GRN.LN) Interim Result, Escher Group (ESCH.LN) Interim Result, Pennant International Group PLC (PEN.
DIRECTOR DEALINGS: Dechra Executives Awarded Shares, Sell Some
LONDON (Alliance News) - Dechra Pharmaceuticals PLC Friday said Chief Executive Ian Page and Company Secretary Zoe Goulding exercised options under the Long Term Incentive Plan and sold some of the shares Thursday.
Patterson Companies Q1 Profit Rises - Update
Analysts had a consensus revenue estimate of $1.04 billion for the quarter. Patterson said the acquisition of National Veterinary Services Ltd.
Related articles »